Details for New Drug Application (NDA): 005929
✉ Email this page to a colleague
NDA 005929 describes D.H.E. 45, which is a drug marketed by Bausch and is included in one NDA. Additional details are available on the D.H.E. 45 profile page.
The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Summary for 005929
| Tradename: | D.H.E. 45 |
| Applicant: | Bausch |
| Ingredient: | dihydroergotamine mesylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 005929
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
